Xenon Pharmaceuticals
XENE
25 hedge funds and large institutions have $45.2M invested in Xenon Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 26 → 25 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
18% less capital invested
Capital invested by funds: $55.4M → $45.2M (-$10.2M)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$3.68M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$3.54M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.5M |
| 4 |
JC
JBF Capital
Aspen,
Colorado
|
+$682K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$497K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.29M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$842K |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$432K |
| 4 |
Renaissance Technologies
New York
|
-$214K |
| 5 |
PA
Perceptive Advisors
New York
|
-$191K |
XENE Hedge Fund Activity: Q3 2015 in Review
25 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Xenon Pharmaceuticals (XENE) for Q3 2015, worth a combined $45.2M — down 18% from $55.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of XENE and 5 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 7 added.
The largest buyer was Capital World Investors, adding an estimated $3.68M. The largest seller was Fidelity Investments, cutting an estimated $2.29M.
- 25 institutional investors held Xenon Pharmaceuticals (XENE) as of Q3 2015, down from 26 in Q2 2015.
- Funds reported $45.2M of Xenon Pharmaceuticals stock for Q3 2015, down 18% quarter-over-quarter.
- 5 funds opened new Xenon Pharmaceuticals positions in Q3 2015 and 6 closed out, a net change of -1 holder.
- The largest Xenon Pharmaceuticals buyer in Q3 2015 was Capital World Investors, an estimated $3.68M added.
- The largest Xenon Pharmaceuticals seller in Q3 2015 was Fidelity Investments, an estimated $2.29M sold.
Based on aggregated 13F filings for Q3 2015.